Scroll down to find a library of Psoriasis related clinical papers.
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber et al.
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-tosevere psoriasis through 5 years of treatment (SCULPTURE Extension Study)
R. Bissonnette et al.
Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
Sebastian Spindeldreher et al.
The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
Jerry Bagel et al.
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Andrew Blauvelt et al.
Secukinumab shows significant efficacy in palmoplantar psoriasis: results from GESTURE, a randomized controlled trial
Alice Gottlieb et al.